Early Use of Hyperimmune Plasma in COVID-19
Clinical trial NCT04721236 · UNKNOWN
Trial details
- NCT number
- NCT04721236
- Sponsor
- Catherine Klersy
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-05-19
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.